Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill (VASTVALUS)

This study has been completed.
Information provided by (Responsible Party):
University of Alberta Identifier:
First received: July 20, 2009
Last updated: December 15, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)